MedPath

Post operative Pain Management -A comparative study of two different doses of Dexmedetomedine as an adjuvant to Bupivacaine in epidural infusion.

Not Applicable
Conditions
Health Condition 1: 4- Measurement and Monitoring
Registration Number
CTRI/2023/06/053538
Lead Sponsor
ACS MEDICAL COLLEGE AND HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ALL PATIENTS WILLING FOR STUDY.

PATIENTS WITH BOTH GENDERS

PATIENTS WHO ARE CONSIOUS AND ORIENTED

ALL PATIENTS UNDERGOING SURGERIES BELOW LEVEL OF UMBILICUS

ALL PATIENTS UNDER ASA 1, ASA 2, ASA 3 CATEGORIES,

ALL PATIENTS UNDERGOING SURGERIES WITH SOLO EPIDURAL PROCEDURE, EPIDURAL WITH SPINAL WITH SPINAL DRUG WITH NO ADJUVANTS ,

Exclusion Criteria

PATIENTS WHO REFUSE FOR PROSEDURE

PREGNANT PATIENTS

PATIENTS WITH SPINAL BIRTH DEFECTS,HEMATOLOGICAL CONDITIONS ,HEMOSTATIC DISORDERS

OBESE PATIENTS

PATIENTS WITH CHRONIC BACK PAIN

PSYCHIATRIC PATIENTS

UNCONSIOUS,NOT ORIENTED,COMATOSED PATIENTS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) HAEMODYNAMIC AND RESPIRATORY PARAMETERS ( BP,PULSE,SPO2,MAP) <br/ ><br> <br/ ><br>2) VISUAL ANALOGUE PAIN SCORE MONITORING DURING PROCEDURE <br/ ><br>(VAS SCORE 1 TO 10)Timepoint: 1.at beginning of epidural infusion <br/ ><br>2.at 5 min after first dose <br/ ><br>3.at 10 min after beginning infusion <br/ ><br>4.at 20 min after beginning of infusion <br/ ><br>5.at 1hr after beginning of infusion <br/ ><br>6.at 6hrs after beginning of infusion <br/ ><br>7.at 12 hrs after beginning of infusion <br/ ><br>8.at 24hrs after beginning of infusion
Secondary Outcome Measures
NameTimeMethod
1) DOSE OF DRUG AT WHICH PATIENT GETS MAXIMUM PAIN RELIEF.Timepoint: DURING THE PROCEDURE
© Copyright 2025. All Rights Reserved by MedPath